Janssen sends off NDA for new multiple sclerosis drug ponesimod
Johnson & Johnson has handed in its NDA for its multiple sclerosis hopeful as it hopes to get in on this blockbuster market.

Previous Article
Next Article
Apr 10, 2020 0 27
Mar 6, 2020 0 21
Mar 25, 2020 0 18
Mar 17, 2020 0 16
Mar 13, 2020 0 15
Mar 13, 2020 0 403
Mar 6, 2020 0 177
Credit: Physical Review Letters Google is racing to develop quantum enhanced processors...
Mar 13, 2020 0 173
The once richly valued biotech cited manufacturing challenges at a contractor as...
Apr 9, 2020 0 151
The test identifies most common chromosomal abnormalities when used alone or in...
May 22, 2020 0 119
A nanoparticle steroid therapy developed by Swiss biotech Oculis has reduced eye...
Apr 10, 2020 0 155
Pfizer has found a leading experimental drug candidate against SARS-CoV-2 and is...
Apr 10, 2020 0 139
Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, April 9, 2020–The new,...
Mar 6, 2020 0 166
A team of UK and Belgian scientists has reported that drug companies spend up to...
Apr 30, 2020 0 130
AstraZeneca has downplayed the risk COVID-19 poses to its clinical trial timelines,...